BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

We are proud to be recognized on the Deloitte 2020 Technology Fast 500 list

Contact

Corporate Headquarters

4131 Parklake Avenue, Suite 225 Raleigh, NC 27612

Tel: 919-582-9050 Toll-free: 1-877-579-4578 Fax: 919-582-9051

Asterisks denote required fields

Recent BDSI News

July 22, 2021

RALEIGH, N.C. , July 22, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its second quarter 2021

Read more
May 6, 2021

Total Company Net Revenue of $41 Million , an Increase of 7% versus Prior Year Net Income of $5.2 Million , EBITDA Margin of 22% and Operating Cash Generation of $11 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C. , May 06, 2021 (GLOBE NEWSWIRE) -- BioDelivery

Read more
April 20, 2021

RALEIGH, N.C. , April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021

Read more
More news

Upcoming Events

BDSI Second Quarter 2021 Financial Results Call and Webcast August 4, 2021 8:30 AM EDT

Stay Connected

Stay up to date on the latest news

Get started now
July 23, 2021BDSI $3.65/ - -1.08%
Data provided by Nasdaq. Minimum 15 minutes delayed.